127 related articles for article (PubMed ID: 10697313)
1. Intraoperative heparin in addition to postoperative low-molecular-weight heparin for thromboprophylaxis in total knee replacement.
Mant MJ; Russell DB; Johnston DW; Donahue PA
J Bone Joint Surg Br; 2000 Jan; 82(1):48-9. PubMed ID: 10697313
[TBL] [Abstract][Full Text] [Related]
2. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
[TBL] [Abstract][Full Text] [Related]
3. Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.
Sun G; Wu J; Wang Q; Liang Q; Jia J; Cheng K; Sun G; Wang Z
J Arthroplasty; 2019 Apr; 34(4):789-800.e6. PubMed ID: 30685261
[TBL] [Abstract][Full Text] [Related]
4. Enoxaparin and heparin comparison of deep vein thrombosis prophylaxis in total hip replacement patients.
Senaran H; Acaroğlu E; Ozdemir HM; Atilla B
Arch Orthop Trauma Surg; 2006 Jan; 126(1):1-5. PubMed ID: 16333632
[TBL] [Abstract][Full Text] [Related]
5. Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis.
Schiff RL; Kahn SR; Shrier I; Strulovitch C; Hammouda W; Cohen E; Zukor D
Chest; 2005 Nov; 128(5):3364-71. PubMed ID: 16304285
[TBL] [Abstract][Full Text] [Related]
6. Dabigatran: new drug. Continue to use heparin, a better-known option.
Prescrire Int; 2009 Jun; 18(101):97-9. PubMed ID: 19637411
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial.
McLeod RS; Geerts WH; Sniderman KW; Greenwood C; Gregoire RC; Taylor BM; Silverman RE; Atkinson KG; Burnstein M; Marshall JC; Burul CJ; Anderson DR; Ross T; Wilson SR; Barton P;
Ann Surg; 2001 Mar; 233(3):438-44. PubMed ID: 11224634
[TBL] [Abstract][Full Text] [Related]
8. Deep vein thrombosis prevention in joint arthroplasties: continuous enhanced circulation therapy vs low molecular weight heparin.
Gelfer Y; Tavor H; Oron A; Peer A; Halperin N; Robinson D
J Arthroplasty; 2006 Feb; 21(2):206-14. PubMed ID: 16520208
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of postdischarge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement. A prospective randomised double-blind placebo-controlled trial.
Planes A; Vochelle N; Darmon JY; Fagola M; Bellaud M; Compan D; Saliba E; Weisslinger N; Huet Y
Drugs; 1996; 52 Suppl 7():47-54. PubMed ID: 9042560
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis of DVT with enoxaparin in patients undergoing total knee replacement.
Niazi AU; Umer M; Umar M
J Pak Med Assoc; 2006 Feb; 56(2):72-5. PubMed ID: 16555639
[TBL] [Abstract][Full Text] [Related]
11. [Thromboprophylaxis with enoxaparin for total knee replacement: an observational, retrospective and multicentre study comparing starting the treatment before and after the operation].
Llau JV; Gil-Garay E; Castellet E;
Rev Esp Anestesiol Reanim; 2012; 59(6):306-14. PubMed ID: 22738999
[TBL] [Abstract][Full Text] [Related]
12. Rates of proximal deep vein thrombosis as assessed by compression ultrasonography in patients receiving prolonged thromboprophylaxis with low molecular weight heparin after major orthopedic surgery.
Schellong S; Hesselschwerdt HJ; Paar WD; von Hanstein KL
Thromb Haemost; 2005 Sep; 94(3):532-6. PubMed ID: 16268468
[TBL] [Abstract][Full Text] [Related]
13. The study of the thrombin generation mechanism and the effect of low molecular weight heparin as thromboprophylaxis in patients undergoing total knee and hip replacement.
Gionis MN; Ioannou CV; Katsamouris AN; Katonis P; Balalis K; Sfyridaki K; Elalamy I; Gerotziafas GT
Thromb Res; 2013; 132(6):685-91. PubMed ID: 24182549
[TBL] [Abstract][Full Text] [Related]
14. A randomised comparison of a foot pump and low-molecular-weight heparin in the prevention of deep-vein thrombosis after total knee replacement.
Warwick D; Harrison J; Whitehouse S; Mitchelmore A; Thornton M
J Bone Joint Surg Br; 2002 Apr; 84(3):344-50. PubMed ID: 12002490
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial.
Warwick D; Harrison J; Glew D; Mitchelmore A; Peters TJ; Donovan J
J Bone Joint Surg Am; 1998 Aug; 80(8):1158-66. PubMed ID: 9730125
[TBL] [Abstract][Full Text] [Related]
16. Prevention of deep vein thrombosis in knee arthroplasty. Preliminary results from a randomized controlled study of low molecular weight heparin vs foot pump compression.
Norgren L; Toksvig-Larsen S; Magyar G; Lindstrand A; Albrechtsson U
Int Angiol; 1998 Jun; 17(2):93-6. PubMed ID: 9754896
[TBL] [Abstract][Full Text] [Related]
17. Use of low molecular weight heparin for prevention of deep vein thrombosis in total knee arthroplasty--a study of its efficacy in an Asian population.
Fong YK; Ruban P; Yeo SJ; Lee BP; Lo NN; Seow KH; Ng SC
Ann Acad Med Singap; 2000 Jul; 29(4):439-41. PubMed ID: 11056771
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two low-molecular-weight heparins for the prevention of postoperative venous thromboembolism after elective hip surgery. Reviparin Study Group.
Planès A; Vochelle N; Fagola M; Bellaud M
Blood Coagul Fibrinolysis; 1998 Sep; 9(6):499-505. PubMed ID: 9819000
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery.
Bara L; Planes A; Samama MM
Br J Haematol; 1999 Feb; 104(2):230-40. PubMed ID: 10050702
[TBL] [Abstract][Full Text] [Related]
20. A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.
Lynd LD; Goeree R; Crowther MA; O'Brien BJ
Can J Clin Pharmacol; 2007; 14(2):e215-26. PubMed ID: 17652767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
